Research Article
Advantages of Sirolimus in a Calcineurin-Inhibitor Minimization Protocol for the Immunosuppressive Management of Kidney Allograft Recipients
Table 1
Effect of donor type on graft rejection or loss.
| | Donor type | Total cases | Rejection or graft loss cases | Percent rejection or graft loss |
| | Living-related donor | 45 | 5 | 11.1% | | Living-unrelated donor | 58 | 8 | 13.3% | | Cadaveric donor | 2 | 1 | 50.0% |
|
|
